Usefulness of the GenMark ePlex RPP assay for the detection of respiratory viruses in comparison with the FTD21 multiplex RT-PCR
Cartridge-based multiplex panels overlaying quite a few pathogens provide a bonus of minimal hands-on-time and quick time to consequence to business RT-PCR assays. On this research, we evaluated the efficiency of the ePlex respiratory pathogen panel (RPP) in comparison with the Quick Monitor Diagnostics Respiratory pathogens 21 multiplex RT-PCR assay (FTD21) utilizing 400 medical respiratory samples. Discrepant outcomes had been additional analysed by a reference nucleic acid amplification testing (NAT) and a composite reference method was used for ultimate interpretation. Discordant outcomes had been noticed in 56 targets equivalent to 54 samples. Sensitivities and specificities had been 85.5% and 99.9% for the ePlex RPP and 95.8% and 99.7% for the FTD21 system, respectively. Altogether, the ePlex RPP is a worthwhile device for the speedy detection of quite a lot of completely different respiratory viruses apart from the coronavirus household (low sensitivity starting from 50-80%) and samples with a low pathogen load (Ct values >33).
Genorise® Semen DNA Extraction Kit 500 |
|||
| GR101041 | Genorise Scientific | 500 | EUR 480 |
Genorise® Semen DNA Extraction Kit 200 |
|||
| GR101042 | Genorise Scientific | 200 | EUR 258 |
Genorise® Semen DNA Extraction Kit 100 |
|||
| GR101043 | Genorise Scientific | 100 | EUR 144 |
Genorise® Semen DNA Extraction Kit 50 |
|||
| GR101044 | Genorise Scientific | 50 | EUR 87 |
Genorise® Semen Stain DNA Extraction Kit 1000 |
|||
| GR101017 | Genorise Scientific | 1000 | EUR 1045 |
Genorise® Semen Stain DNA Extraction Kit 500 |
|||
| GR101069 | Genorise Scientific | 500 | EUR 564 |
Genorise® Semen Stain DNA Extraction Kit 200 |
|||
| GR101070 | Genorise Scientific | 200 | EUR 243 |
Genorise® Semen Stain DNA Extraction Kit 100 |
|||
| GR101071 | Genorise Scientific | 100 | EUR 144 |
Genorise® Semen Stain DNA Extraction Kit 50 |
|||
| GR101072 | Genorise Scientific | 50 | EUR 87 |
AI-91K LN2 Freezer for Bulk Semen Storage, no controller |
|||
| TW-AI-91K | MiTeGen | 1 UNIT | EUR 66671 |
|
Description: AI-91K LN2 Freezer for Bulk Semen Storage, no controller |
|||
Semenogelin I Protein |
|||
| 20-abx261182 | Abbexa |
|
|
Semenogelin I antibody |
|||
| 70R-1587 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal Semenogelin I antibody raised against the N terminal of SEMG1 |
|||
Semenogelin I antibody |
|||
| 70R-1593 | Fitzgerald | 100 ug | EUR 452.4 |
|
Description: Rabbit polyclonal Semenogelin I antibody raised against the C terminal of SEMG1 |
|||
Semenogelin I antibody |
|||
| 70R-5491 | Fitzgerald | 50 ug | EUR 560.4 |
|
Description: Rabbit polyclonal Semenogelin I antibody raised against the middle region of SEMG1 |
|||
Semenogelin I (SEMG1) Antibody |
|||
| 20-abx115422 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
| 20-abx320262 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
| 20-abx322135 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
| 20-abx004204 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
| 20-abx174508 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
| abx237711-100ug | Abbexa | 100 ug | EUR 661.2 |
Semenogelin I (SEMG1) Antibody |
|||
| 20-abx129235 | Abbexa |
|
|
Semenogelin I (SEMG1) Antibody |
|||
| abx028130-400ul | Abbexa | 400 ul | EUR 627.6 |
Semenogelin I (SEMG1) Antibody |
|||
| abx028130-80l | Abbexa | 80 µl | EUR 343.2 |
Recombinant Semenogelin I (SEMG1) |
|||
| 4-RPH185Hu01 | Cloud-Clone |
|
|
|
Description: Recombinant Human Semenogelin I expressed in: E.coli |
|||
Semenogelin I Blocking Peptide |
|||
| 33R-3239 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-1593 |
|||
Semenogelin I Blocking Peptide |
|||
| 33R-4289 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-5491 |
|||
Semenogelin I Blocking Peptide |
|||
| 33R-7601 | Fitzgerald | 100 ug | EUR 216 |
|
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of SEMG1 antibody, catalog no. 70R-1587 |
|||
Human Semenogelin I (SEMG1) Protein |
|||
| 20-abx168081 | Abbexa |
|
|
Human Semenogelin I (SEMG1) CLIA Kit |
|||
| 20-abx495402 | Abbexa |
|
|
Lung Diabetic Disease Lysate |
|||
| XBL-10362 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human lung tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human lung tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the lung tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The lung tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| 20-abx153055 | Abbexa |
|
|
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| DLR-SEMG1-Hu-48T | DL Develop | 48T | EUR 620.4 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma or other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| DLR-SEMG1-Hu-96T | DL Develop | 96T | EUR 807.6 |
|
Description: A sandwich quantitative ELISA assay kit for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma or other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| abx250766-96tests | Abbexa | 96 tests | EUR 904.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| abx571776-96tests | Abbexa | 96 tests | EUR 904.8 |
Human Semenogelin I(SEMG1)ELISA Kit |
|||
| QY-E01566 | Qayee Biotechnology | 96T | EUR 448.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RD-SEMG1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 625.2 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RD-SEMG1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 867.6 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RDR-SEMG1-Hu-48Tests | Reddot Biotech | 48 Tests | EUR 652.8 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RDR-SEMG1-Hu-96Tests | Reddot Biotech | 96 Tests | EUR 907.2 |
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| SEH185Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | EUR 5677.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| SEH185Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | EUR 572.76 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| SEH185Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | EUR 766.8 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| SEH185Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | EUR 3090.6 |
|
Description: This is Double-antibody Sandwich Enzyme-linked immunosorbent assay for detection of Human Semenogelin I (SEMG1) in serum, plasma, seminal plasma and other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| 4-SEH185Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Double-antibody Sandwich method for detection of Human Semenogelin I (SEMG1) in samples from serum, plasma, seminal plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RD-SEMG1-Hu-48T | Reddot Biotech | 48T | EUR 452.7 |
|
Description: serum, plasma, seminal plasma and other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RD-SEMG1-Hu-96T | Reddot Biotech | 96T | EUR 646.7 |
|
Description: serum, plasma, seminal plasma and other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RDR-SEMG1-Hu-48T | Reddot Biotech | 48T | EUR 475.34 |
|
Description: serum, plasma, seminal plasma and other biological fluids. |
|||
Human Semenogelin I (SEMG1) ELISA Kit |
|||
| RDR-SEMG1-Hu-96T | Reddot Biotech | 96T | EUR 679.04 |
|
Description: serum, plasma, seminal plasma and other biological fluids. |
|||
Total RNA - Diabetic Disease: Colon |
|||
| R1236090Dia-50 | Biochain | 50 ug | EUR 421.2 |
Colon Diabetic Disease Lysate |
|||
| XBL-10333 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human colon tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human colon tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the colon tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The colon tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Ileum Diabetic Disease Lysate |
|||
| XBL-10379 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human small intestine: Ileum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Ileum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Ileum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Ileum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Total RNA - Diabetic Disease: Stomach |
|||
| R1236248Dia-50 | Biochain | 50 ug | EUR 421.2 |
Jejunum Diabetic Disease Lysate |
|||
| XBL-10381 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human small intestine: Jejunum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human small intestine: Jejunum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the small intestine: Jejunum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The small intestine: Jejunum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Stomach Diabetic Disease Lysate |
|||
| XBL-10387 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human stomach tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human stomach tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the stomach tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The stomach tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Total RNA - Diabetic Disease: Pancreas |
|||
| R1236188Dia-50 | Biochain | 50 ug | EUR 421.2 |
Duodenum Diabetic Disease Lysate |
|||
| XBL-10336 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human duodenum tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human duodenum tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the duodenum tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The duodenum tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
ELISA kit for Human SEMG1 (Semenogelin I) |
|||
| ELK4641 | ELK Biotech | 1 plate of 96 wells | EUR 518.4 |
|
Description: A sandwich ELISA kit for detection of Semenogelin I from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Total RNA - Diabetic Disease: Esophagus |
|||
| R1236106Dia-50 | Biochain | 50 ug | EUR 421.2 |
Esophagus Diabetic Disease Lysate |
|||
| XBL-10338 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human esophagus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human esophagus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the esophagus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The esophagus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Pancrease Diabetic Disease Lysate |
|||
| XBL-10371 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: Human pancrease tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human pancrease tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the pancrease tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The pancrease tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
cDNA - Human Diabetic Diseased Tissue: Lung |
|||
| C1236152Dia | Biochain | 40 reactions | EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Skin |
|||
| C1236218Dia | Biochain | 40 reactions | EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Brain |
|||
| C1236035Dia | Biochain | 40 reactions | EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Colon |
|||
| C1236090Dia | Biochain | 40 reactions | EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Heart |
|||
| C1236122Dia | Biochain | 40 reactions | EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Liver |
|||
| C1236149Dia | Biochain | 40 reactions | EUR 729 |
SEMG1 Semenogelin I Human Recombinant Protein |
|||
| PROTP04279 | BosterBio | Regular: 20ug | EUR 380.4 |
|
Description: SEMG1 Human Recombinant produced in E. coli is a single polypeptide chain containing 462 amino acids (24-462) and having a molecular mass of 52kDa. SEMG1 is fused to a 23 amino acid His-tag at N-terminus & purified by proprietary chromatographic techniques. |
|||
Semenogelin I (SEMG1) Polyclonal Antibody (Human) |
|||
| 4-PAH185Hu01 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1) |
|||
cDNA - Human Diabetic Diseased Tissue: Whole Eye |
|||
| C1236108Dia-10 | Biochain | 10 reactions | EUR 393 |
cDNA - Human Diabetic Diseased Tissue: Kidney |
|||
| C1236142Dia | Biochain | 40 reactions | EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Spleen |
|||
| C1236246Dia | Biochain | 40 reactions | EUR 729 |
Skeletal Muscle Diabetic Disease Lysate |
|||
| XBL-10369 | ProSci | 0.1 mg | EUR 796.2 |
|
Description: human skeletal muscle tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human skeletal muscle tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the Skeletal Muscle tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The Skeletal Muscle tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Collagen Type I (Collagen Type I) Antibody |
|||
| abx231836-100ug | Abbexa | 100 ug | EUR 610.8 |
Collagen Type I (Collagen Type I) Antibody |
|||
| abx022733-05ml | Abbexa | 0.5 ml | EUR 1713.6 |
Collagen Type I (Collagen Type I) Antibody |
|||
| abx022734-02mg | Abbexa | 0.2 mg | EUR 1312.8 |
Collagen Type I (Collagen Type I) Antibody |
|||
| abx022736-05ml | Abbexa | 0.5 ml | EUR 1696.8 |
Collagen Type I (Collagen Type I) Antibody |
|||
| abx022737-05ml | Abbexa | 0.5 ml | EUR 1412.4 |
Collagen Type I (Collagen Type I) Antibody |
|||
| abx020882-100ug | Abbexa | 100 ug | EUR 1161.6 |
Collagen Type I (Collagen Type I) Antibody |
|||
| 20-abx101265 | Abbexa |
|
|
Collagen Type I (Collagen Type I) Antibody |
|||
| 20-abx101266 | Abbexa |
|
|
Collagen Type I (Collagen Type I) Antibody |
|||
| 20-abx130515 | Abbexa |
|
|
cDNA - Human Diabetic Diseased Tissue: Lymph Node |
|||
| C1236161Dia-10 | Biochain | 10 reactions | EUR 393 |
cDNA - Human Diabetic Diseased Tissue: Stomach |
|||
| C1236248Dia | Biochain | 40 reactions | EUR 729 |
cDNA - Human Diabetic Diseased Tissue: Bone Marrow |
|||
| C1236024Dia-10 | Biochain | 10 reactions | EUR 420 |
cDNA - Human Diabetic Diseased Tissue: Pancreas |
|||
| C1236188Dia | Biochain | 40 reactions | EUR 729 |
Pancreas Membrane Diabetic Disease Lysate |
|||
| XBL-10785 | ProSci | 0.1 mg | EUR 752.1 |
|
Description: Human pancreas tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human pancreas tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated pancreas tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated pancreas tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
Semenogelin I (SEMG1) Polyclonal Antibody (Human), PE |
|||
| 4-PAH185Hu01-PE | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with PE. |
|||
cDNA - Human Diabetic Diseased Tissue: Esophagus |
|||
| C1236106Dia | Biochain | 40 reactions | EUR 729 |
Membrane Protein - Diabetic Disease: Pancreas |
|||
| P3236188Dia | Biochain | 0.1 mg | EUR 410 |
Semenogelin I (SEMG1) Polyclonal Antibody (Human), APC |
|||
| 4-PAH185Hu01-APC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with APC. |
|||
Semenogelin I (SEMG1) Polyclonal Antibody (Human), Cy3 |
|||
| 4-PAH185Hu01-Cy3 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with Cy3. |
|||
Semenogelin I (SEMG1) Polyclonal Antibody (Human), HRP |
|||
| 4-PAH185Hu01-HRP | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with HRP. |
|||
Total Protein - Human Diabetic Diseased Tissue: Lung |
|||
| P1236152Dia | Biochain | 1 mg | EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Skin |
|||
| P1236218Dia | Biochain | 1 mg | EUR 471 |
Semenogelin I (SEMG1) Polyclonal Antibody (Human), FITC |
|||
| 4-PAH185Hu01-FITC | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with FITC. |
|||
Adipose Subcutaneous Diabetic Disease Lysate |
|||
| 20-105 | ProSci | 0.1 mg | EUR 1508.1 |
|
Description: Human subcutaneous adipose tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human subcutaneous adipose tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the subcutaneous adipose tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The subcutaneous adipose tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|||
Total Protein - Human Diabetic Diseased Tissue: Brain |
|||
| P1236035Dia | Biochain | 1 mg | EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Colon |
|||
| P1236090Dia | Biochain | 1 mg | EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Heart |
|||
| P1236122Dia | Biochain | 1 mg | EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Liver |
|||
| P1236149Dia | Biochain | 1 mg | EUR 471 |
cDNA - Human Diabetic Diseased Tissue: Skeletal Muscle |
|||
| C1236171Dia | Biochain | 40 reactions | EUR 729 |
Total Protein - Human Diabetic Diseased Tissue: Whole Eye |
|||
| P1236108Dia | Biochain | 1 mg | EUR 1147 |
Total Protein - Human Diabetic Diseased Tissue: Kidney |
|||
| P1236142Dia | Biochain | 1 mg | EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Spleen |
|||
| P1236246Dia | Biochain | 1 mg | EUR 471 |
Skeletal Muscle Membrane Diabetic Disease Lysate |
|||
| XBL-10855 | ProSci | 0.1 mg | EUR 752.1 |
|
Description: human skeletal muscle tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human skeletal muscle tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated Skeletal Muscle tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated Skeletal Muscle tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|||
cDNA - Human Diabetic Diseased Tissue: Visceral Adipose |
|||
| C1236003VisDia-10 | Biochain | 10 reactions | EUR 420 |
Total Protein - Human Diabetic Diseased Tissue: Adrenal |
|||
| P1236004Dia | Biochain | 1 mg | EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Stomach |
|||
| P1236248Dia | Biochain | 1 mg | EUR 471 |
Membrane Protein - Diabetic Disease: Skeletal Muscle |
|||
| P3236171Dia | Biochain | 0.1 mg | EUR 410 |
Total Protein - Human Diabetic Diseased Tissue: Bone Marrow |
|||
| P1236024Dia | Biochain | 1 mg | EUR 1147 |
Total Protein - Human Diabetic Diseased Tissue: Pancreas |
|||
| P1236188Dia | Biochain | 1 mg | EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Eye |
|||
| T1236108Dia | Biochain | 5 slides | EUR 662 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
|||
| C1236227Dia | Biochain | 40 reactions | EUR 729 |
Total Protein - Human Diabetic Diseased Tissue: Esophagus |
|||
| P1236106Dia | Biochain | 1 mg | EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Lung |
|||
| T1236152Dia | Biochain | 5 slides | EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Skin |
|||
| T1236218Dia | Biochain | 5 slides | EUR 475 |
Semenogelin I (SEMG1) Polyclonal Antibody (Human), APC-Cy7 |
|||
| 4-PAH185Hu01-APC-Cy7 | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with APC-Cy7. |
|||
Frozen Tissue Section - Human Diabetic Diseased Tissue: Brain |
|||
| T1236035Dia | Biochain | 5 slides | EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Colon |
|||
| T1236090Dia | Biochain | 5 slides | EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Heart |
|||
| T1236122Dia | Biochain | 5 slides | EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Liver |
|||
| T1236149Dia | Biochain | 5 slides | EUR 475 |
Semenogelin I (SEMG1) Polyclonal Antibody (Human), Biotinylated |
|||
| 4-PAH185Hu01-Biotin | Cloud-Clone |
|
|
|
Description: A Rabbit polyclonal antibody against Human Semenogelin I (SEMG1). This antibody is labeled with Biotin. |
|||
cDNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
|||
| C1236003SubDia-10 | Biochain | 10 reactions | EUR 420 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
|||
| C1236230Dia | Biochain | 40 reactions | EUR 729 |
Genomic DNA - Human Diabetic Diseased Tissue: Lung, from a single donor |
|||
| D1236152Dia | Biochain | 50 ug | EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Skin, from a single donor |
|||
| D1236218Dia | Biochain | 50 ug | EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Kidney |
|||
| T1236142Dia | Biochain | 5 slides | EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Spleen |
|||
| T1236246Dia | Biochain | 5 slides | EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Lung |
|||
| T2236152Dia | Biochain | 5 slides | EUR 238 |
cDNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
|||
| C1236101Dia | Biochain | 40 reactions | EUR 729 |
Genomic DNA - Human Diabetic Diseased Tissue: Brain, from a single donor |
|||
| D1236035Dia | Biochain | 50 ug | EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Colon, from a single donor |
|||
| D1236090Dia | Biochain | 50 ug | EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Heart, from a single donor |
|||
| D1236122Dia | Biochain | 50 ug | EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Liver, from a single donor |
|||
| D1236149Dia | Biochain | 50 ug | EUR 489 |
Total Protein - Human Diabetic Diseased Tissue: Skeletal Muscle |
|||
| P1236171Dia | Biochain | 1 mg | EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Adrenal |
|||
| T1236004Dia | Biochain | 5 slides | EUR 475 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Stomach |
|||
| T1236248Dia | Biochain | 5 slides | EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Colon |
|||
| T2236090Dia | Biochain | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Liver |
|||
| T2236149Dia | Biochain | 5 slides | EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Whole Eye, from a single donor |
|||
| D1236108Dia | Biochain | 50 ug | EUR 1152 |
Genomic DNA - Human Diabetic Diseased Tissue: Kidney, from a single donor |
|||
| D1236142Dia | Biochain | 50 ug | EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Spleen, from a single donor |
|||
| D1236246Dia | Biochain | 50 ug | EUR 489 |
Total Protein - Human Diabetic Diseased Tissue: Visceral Adipose |
|||
| P1236003VisDia | Biochain | 1 mg | EUR 1147 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow |
|||
| T1236024Dia | Biochain | 5 slides | EUR 662 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Pancreas |
|||
| T1236188Dia | Biochain | 5 slides | EUR 475 |
Genomic DNA - Human Diabetic Diseased Tissue: Adrenal, from a single donor |
|||
| D1236004Dia | Biochain | 50 ug | EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Stomach, from a single donor |
|||
| D1236248Dia | Biochain | 50 ug | EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Esophagus |
|||
| T1236106Dia | Biochain | 5 slides | EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Stomach |
|||
| T2236248Dia | Biochain | 5 slides | EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Bone Marrow, from a single donor |
|||
| D1236024Dia | Biochain | 50 ug | EUR 1152 |
Genomic DNA - Human Diabetic Diseased Tissue: Esophagus, from a single donor |
|||
| D1236106Dia | Biochain | 50 ug | EUR 489 |
Genomic DNA - Human Diabetic Diseased Tissue: Pancreas, from a single donor |
|||
| D1236188Dia | Biochain | 50 ug | EUR 489 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
|||
| P1236227Dia | Biochain | 1 mg | EUR 471 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Bone Marrow |
|||
| T2236024Dia | Biochain | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Esophagus |
|||
| T2236106Dia | Biochain | 5 slides | EUR 238 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Pancreas |
|||
| T2236188Dia | Biochain | 5 slides | EUR 238 |
Total Protein - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
|||
| P1236003SubDia | Biochain | 1 mg | EUR 1147 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
|||
| P1236101Dia | Biochain | 1 mg | EUR 471 |
Total Protein - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
|||
| P1236230Dia | Biochain | 1 mg | EUR 471 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Visceral Adipose |
|||
| T1236003VisDia | Biochain | 5 slides | EUR 662 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle |
|||
| T1236171Dia | Biochain | 5 slides | EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Parathyroid |
|||
| T2236189Dia | Biochain | 5 slides | EUR 629 |
Genomic DNA - Human Diabetic Diseased Tissue: Visceral Adipose, from a single donor |
|||
| D1236003VisDia | Biochain | 50 ug | EUR 1152 |
Genomic DNA - Human Diabetic Diseased Tissue: Skeletal Muscle, from a single donor |
|||
| D1236171Dia | Biochain | 50 ug | EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
|||
| T1236227Dia | Biochain | 5 slides | EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Skeletal Muscle |
|||
| T2236171Dia | Biochain | 5 slides | EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Ileum, from a single donor |
|||
| D1236227Dia | Biochain | 50 ug | EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Subcutaneous Adipose |
|||
| T1236003SubDia | Biochain | 5 slides | EUR 662 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
|||
| T1236230Dia | Biochain | 5 slides | EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Ileum |
|||
| T2236227Dia | Biochain | 5 slides | EUR 238 |
Genomic DNA - Human Diabetic Diseased Tissue: Subcutaneous Adipose, from a single donor |
|||
| D1236003SubDia | Biochain | 50 ug | EUR 1152 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Jejunum, from a single donor |
|||
| D1236230Dia | Biochain | 50 ug | EUR 489 |
Frozen Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
|||
| T1236101Dia | Biochain | 5 slides | EUR 475 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Jejunum |
|||
| T2236230Dia | Biochain | 5 slides | EUR 238 |
Procollagen Type I (212-216) |
|||
| H-1592.0005 | Bachem | 5.0mg | EUR 151.2 |
|
Description: Sum Formula: C23H45N7O9; CAS# [149128-48-3] |
|||
Procollagen Type I (212-216) |
|||
| H-1592.0025 | Bachem | 25.0mg | EUR 501.6 |
|
Description: Sum Formula: C23H45N7O9; CAS# [149128-48-3] |
|||
Collagen Type I protein |
|||
| 30R-AC016 | Fitzgerald | 500 ug | EUR 528 |
|
Description: Purified native Human Collagen Type I Solution |
|||
Collagen Type I protein |
|||
| E62L001 | EnoGene | 1mg | EUR 1425.6 |
Genomic DNA - Human Diabetic Diseased Tissue: Small Intestine: Duodenum, from a single donor |
|||
| D1236101Dia | Biochain | 50 ug | EUR 489 |
Paraffin Tissue Section - Human Diabetic Diseased Tissue: Small Intestine: Duodenum |
|||
| T2236101Dia | Biochain | 5 slides | EUR 238 |
Collagen Type I antibody |
|||
| 10-1800 | Fitzgerald | 200 ul | EUR 846 |
|
Description: Mouse monoclonal Collagen Type I antibody |
|||
Collagen Type I antibody |
|||
| 10R-C139b | Fitzgerald | 100 ug | EUR 976.8 |
|
Description: Mouse monoclonal Collagen Type I antibody |
|||
Collagen Type I antibody |
|||
| 70R-CR007x | Fitzgerald | 100 µg | EUR 379.2 |
|
Description: Affinity purified Rabbit polyclonal Collagen Type I antibody |
|||
Collagen Type I antibody |
|||
| 20R-CR025 | Fitzgerald | 500 ul | EUR 950.4 |
|
Description: Rabbit polyclonal Collagen Type I antibody |
|||
Collagen Type I antibody |
|||
| PAab09910 | Lifescience Market | 100 ug | EUR 463.2 |
Procollagen Type I protein |
|||
| E62L008 | EnoGene | 100ug | EUR 1035.6 |
Type I Safety Can 4L |
|||
| SAF7976 | Scientific Laboratory Supplies | EACH | EUR 143.62 |
Mixture of a SARS-CoV-2 IgG Assay and RT-PCR for Improved COVID-19 Analysis
Background: Coronavirus illness 2019 (COVID-19), brought on by extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is mostly recognized by reverse transcription (RT)-PCR or serological assays. The SARS-CoV-2 viral load decreases just a few days after symptom onset. Thus, the RT-PCR sensitivity peaks at three days after symptom onset (roughly 80%). We evaluated the efficiency of the ARCHITECT® SARS-CoV-2 IgG assay (henceforth termed IgG assay; Abbott Laboratories, Lake County, IL, USA), and the mixture of RT-PCR and the IgG assay for COVID-19 analysis.
Strategies: On this retrospective research, 206 samples from 70 COVID-19 instances at two hospitals in Tokyo that had been constructive utilizing RT-PCR had been used to investigate the diagnostic sensitivity. RT-PCR-negative (N=166), COVID-19-unrelated (N=418), and Japanese Pink Cross Society (N=100) samples had been used to guage specificity.
Outcomes: Sensitivity elevated day by day after symptom onset and exceeded 84.4% after 10 days. Specificity ranged from 98.2% to 100% for samples from the three case teams. Seroconversion was confirmed from 9 to 20 days after symptom onset in 18 out of 32 COVID-19 instances with a number of samples and from one other case with a constructive consequence within the IgG assay for the primary accessible pattern.
Conclusions: The mix of RT-PCR and IgG assay improves the robustness of laboratory diagnostics by compensating for the constraints of every technique.
Simultaneous Molecular Detection of Frequent Bacterial Enteropathogens in Youngsters with Diarrhea by Multiplex-PCR Assay
Background: Diarrhea stays a serious risk to kids in low- and middle-income international locations, which is the second explanation for dying amongst kids on the planet. The intention of the current research was to develop and consider a multiplex-PCR assay for direct detection of widespread bacterial enteropathogens in fecal specimens.
Strategies: 100 and three stool specimens had been collected from kids beneath 5 years of age with gastroenteritis throughout a six-month interval in Ilam, Iran. The multiplex PCR assay concurrently detected Shigella spp., Campylobacter jejuni, Enteropathogenic Escherichia coli (EPEC), Enterotoxigenic Escherichia coli (ETEC), and Salmonella enterica in stool samples.
Outcomes: Our outcomes demonstrated that the prevalence of Shigella spp. Campylobacter jejuni, EPEC, ETEC, and Salmonella enterica had been 21.35%, 10.67%, 1.94%, 0.97% and 0%, respectively. As well as, Shigella spp. with Campylobacter jejuni and EPEC with Campylobacter jejuni coinfection had been noticed in pattern 11 (10.67%). The analytical sensitivity of the multiplex PCR assay was estimated to be 0.01 ng/µL of genomic DNA from tradition. The analytical specificity was decided to be 100% through the use of widespread and customary enteropathogenic bacterial strains.
Conclusions: The molecular technique developed within the research was speedy, delicate, and particular for detection of widespread bacterial enteropathogens.
Screening of ZIKA virus an infection amongst dengue-like sickness sufferers with damaging RT-PCR for dengue virus in Punjab – Pakistan
Goal: To detect ZIKV utilizing reverse transcription-polymerase chain response (RT-PCR) amongst medical samples examined damaging for Dengue virus (DENV) by RT-PCR in Punjab, 2016.
Strategies: A descriptive cross-sectional research was carried out for length of two months. Whole of 506 samples had been collected inside seven days from onset of sickness from throughout hospitals of Punjab, Pakistan of which 350 had been chosen merely randomly to check for presence of ZIKV through the use of “Trioplex Actual-Time RT-PCR Assay (Trioplex)”. Cohen’s kappa coefficient (κ) and 95% confidence interval (CI) had been used to evaluate the diploma of concordance between DENV constructive outcomes of non-structural protein 1 (NS1) and IgM solid-phase enzyme immunoassay (ELISA).
Outcomes: No samples had been constructive for any ZIKV, DENV or Chikungunya virus (CHIKV) by Trioplex. Among the many 350 samples, 26 samples had been constructive concordant and the diploma of concordance between NS1- and IgM-ELISA was 13% and κ coefficient was -0.71 (95% CI -0.79, -0.63).
Conclusion: At research time, no samples had been constructive for ZIKV. Strengthening laboratory capability to verify arboviruses for Punjab’s laboratories is warranted. Trioplex RT-PCR has 100% sensitivity so there are nominal probabilities of false damaging outcomes. Establishing syndromic surveillance for Zika and conducting a sero-surveillance survey for Zika in areas with excessive human and Aedes mosquito density are advisable in Punjab.
Repositive RT-PCR take a look at in discharged COVID-19 sufferers throughout medical isolation commentary
Targets: The epidemiological and medical traits of sufferers with coronavirus illness 2019 (COVID-19) have been researched. Nonetheless, the prevalence of repositivity by real-time PCR for extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) stays unclear.
Strategies: A retrospective research was carried out involving 599 discharged sufferers with COVID-19 in a single medical centre. The medical options of sufferers throughout their hospitalization and 14-day post-discharge quarantine had been collected.
Outcomes: A complete of 122 sufferers (20.4%) out of 599 sufferers retested constructive after discharge. Particularly, 94 (15.7%) retested constructive inside 24 h of discharge, and one other 28 sufferers (4.7%) had been repositive on day 7 after discharge, though none confirmed any medical symptomatic recurrence. Each repositives and non‑repositives have related patterns of IgG and IgM. Notably, the size of hospitalization of non-repositive sufferers was longer than that of 24-h repositive sufferers and 7-day repositive sufferers. As well as, the size of hospitalization of 24-h repositive sufferers was shorter than that of 7-day repositive sufferers, indicating that the size of hospitalization was additionally a determinant of viral shedding.
Conclusion: Our research supplies additional info for bettering the administration of recovered and discharged sufferers, and additional research must be carried out to elucidate the infectiveness of people with extended or RNA repositivity.